| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 728040 | 2-[4-(methoxy)phenyltio]-3-phenyl-5,7-diamino quinoxaline | 0.00182957917645007 | 0.31486426 |
| NSC 736079 | 4-[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-6-pyrrolidin-1-yl-1 ,3,5-triazin-2-ylamine | 0.00182957917645007 | 0.44951221 |
| NSC 736081 | 4-morpholin-4-yl-6[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-1,3 ,5-triazin-2-ylamine | 0.00182957917645007 | 0.39467163 |
| NSC 743432 | 2-{5-[4-(5-{4-[6-morpholino-1H-benzo[d]imidazole-2-yl]phenoxy}pentyl)piperazino]pentyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione | 0.00182957917645007 | 0.44794494 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.00216534295403404 | 0.51050356 |
| NSC 678040 | Methanone, (tricyclo[3.3.1.1(3,7)]decan-1-yl) [3-(3-nitrophenyl)-2-oxiranyl]- | 0.00216534295403404 | 0.30045127 |
| NSC 687578 | Null | 0.00216534295403404 | 0.25775457 |
| NSC 690248 | Null | 0.00216534295403404 | 0.49231713 |
| NSC 692574 | Null | 0.00216534295403404 | 0.66578398 |
| NSC 693867 | Null | 0.00216534295403404 | 0.50531606 |